Corporate Information

Concord Drugs Ltd Industry : (Pharmaceuticals)

BSE Code : 538965

NSE Symbol : -

P/E(TTM) : -

ISIN Demat : INE858L01010

Div & Yield% : -

EPS(TTM) : -

Book Value(₹) : 33.88

Market Cap(₹Cr) : 37.39

Face Value(₹) : 10.00

  Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
SOURCES OF FUNDS :          
Equity Share Capital 10.00 9.32 8.74 8.74 8.74
Reserves 23.82 21.82 19.62 18.02 14.74
Equity Share Warrants 0.00 0.56 0.00 0.00 0.00
Equity Application Money 0.00 0.00 0.00 0.00 0.00
Total Shareholders Funds 33.82 31.70 28.36 26.76 23.48
Secured Loans 14.93 15.63 16.43 12.96 9.35
Unsecured Loans 0.00 0.00 0.00 0.01 0.22
Total Debt 14.93 15.63 16.43 12.97 9.57
Other Liabilities 2.53 2.46 2.08 2.45 2.54
Total Liabilities 51.28 49.79 46.87 42.18 35.59
APPLICATION OF FUNDS :          
Gross Block 37.92 37.61 37.12 35.22 30.98
Less: Accumulated Depreciation 26.29 24.75 23.15 21.39 20.46
Less:Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Net Block 11.63 12.86 13.97 13.83 10.52
Lease Adjustments 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 1.63 0.92 0.55 0.00 1.00
Investments 1.62 1.42 0.00 0.00 0.00
Current Assets, Loans & Advances          
Inventories 18.50 17.50 17.49 11.87 16.43
Sundry Debtors 21.07 16.35 22.86 20.73 25.45
Cash and Bank Balance 0.17 0.10 0.07 0.06 0.04
Loans and Advances 1.65 7.45 1.48 3.37 3.65
Total Current Assets 41.38 41.40 41.89 36.03 45.56
Less : Current Liabilities and Provisions          
Current Liabilities 4.34 5.95 8.24 6.54 22.16
Provisions 0.20 0.35 0.67 0.47 0.12
Total CL & Provisions 4.54 6.30 8.91 7.01 22.28
Net Current Assets 36.84 35.11 32.98 29.02 23.28
Miscellaneous Expenses not written off 0.00 0.00 0.00 0.00 0.00
Deferred Tax Assets 0.00 0.00 0.00 0.00 0.00
Deferred Tax Liability 0.48 0.54 0.66 0.68 0.14
Net Deferred Tax -0.48 -0.54 -0.66 -0.68 -0.14
Other Assets 0.04 0.04 0.03 0.03 0.93
Total Assets 51.28 49.81 46.87 42.20 35.59
Contingent Liabilities 0.00 0.00 0.00 0.00 0.00